The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrom… (NCT06891001) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity
United States36 participantsStarted 2027-01-01
Plain-language summary
We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compared to physical therapy with sham inserts (PT+Sham) and physical therapy (PT) alone. In addition, we hypothesize that the addition of a neutral shoe insert in the involved limb will immediately improve biomechanics and pain with the single-leg stance test.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects with a history of unilateral hip pain lasting more than three months.
* Subjects with a VAS pain score of at least 3/10 localized to the lateral hip.
* Subjects with pain with palpation to lateral hip.
* Subjects with pain with either resisted hip abduction in relative adduction testing position and/or single leg stance test
Exclusion Criteria:
* Subjects wearing custom foot orthoses at the time of recruitment.
* Subjects who endorse current low back pain ≥ 3 on the NRS or lumbar radiculopathy
* Subjects with a medical history of spinal or lower limb surgery in the past 6 months.
* Subjects with a medical history of total joint replacement of hip, knee, or ankle on the symptomatic side
* Subjects who have had a corticosteroid injection at the hip within the last 12 months;
* Subjects demonstrating clinical signs and symptoms of intra-articular hip joint pathology with ≥ 3/10 groin pain including imaging confirmed significant labral tearing requiring surgery or osteoarthritis \> 2 (mild) on Kellgren-Lawrence score on radiographs.
* Subjects previously diagnosed with systemic inflammatory conditions; active cancer/malignant tumors; or neurological conditions that would affect gait
* Subjects who have had physical therapy within the past 3 months for hip pain
* If subjects are unable to commit to 12 weeks of therapy with one supervised session weekly
* Subjects who have the intention to perform treatments outside of this study including, but not…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Victorian Institute Sport Assessment - Gluteal Questionnaire